Recent Performance: ELF stock has dropped -10.2% over the past month, underperforming both the Zacks S&P 500 composite (+2.1%) and the Zacks Cosmetics industry (+3.1%).
Earnings Estimates:
Current quarter EPS is projected at $0.76, up +2.7% year-over-year, with a +2.6% revision in the last 30 days.
FY23 EPS is expected at $3.61, a +13.5% increase, with a +0.1% revision over 30 days.
FY24 EPS estimate is $4.35, reflecting a +20.6% year-over-year growth, but revised down -0.7% recently.
Revenue Growth:
Current quarter sales estimate: $329.49 million, up +21.6% YoY.
FY23 sales estimate: $1.34 billion, a +30.7% increase.
FY24 sales estimate: $1.57 billion, up +17.4%.
Recent Earnings:
Last quarter revenue: $301.08 million, up +39.7% YoY, beating estimates by +3.38%.
EPS: $0.77, a +71.11% surprise but down from $0.82 last year.
ELF beat revenue and EPS estimates for the last four quarters.
Valuation: ELF scores poorly (grade F) on valuation metrics, suggesting it trades at a premium compared to peers.
The stock's earnings growth and revenue trends are positive, but its high valuation and mixed estimate revisions temper the outlook.
@Tiger_comments @TigerCommunity @TigerWire @TigerEvents @TigerStars
Comments